Adial Pharmaceuticals, Inc. (ADIL) Financials
ADIL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 5.2 million | 1.5 million |
| Dec. 31, 2025 | 6.8 million | 1.5 million |
| Sept. 30, 2025 | 5.7 million | 1.2 million |
| June 30, 2025 | 6.8 million | 1.2 million |
ADIL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -1.6 million | 147900 |
| Dec. 31, 2025 | -1.3 million | 168036 |
| Sept. 30, 2025 | -1.8 million | 147334 |
| June 30, 2025 | -1.7 million | 124099 |
ADIL Net Income
No data available :(
ADIL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 4.6 million | - | - |
| Dec. 31, 2025 | 5.9 million | - | - |
| Sept. 30, 2025 | 4.6 million | - | - |
| June 30, 2025 | 5.9 million | - | - |
ADIL Shares Outstanding
ADIL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 432530 | 1.6 million | - |
| Dec. 31, 2025 | 4 | 619396 | 1.3 million | - |
| Sept. 30, 2025 | 3 | 521069 | 1.2 million | - |
| June 30, 2025 | - | 732315 | 1.2 million | - |
ADIL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 141 |
| Dec. 31, 2025 | - | 142 |
| Sept. 30, 2025 | - | 141 |
| June 30, 2025 | - | 141 |
ADIL
Price: $2.60
52 week price:
Earnings Per Share: -4.89 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 498900
Market Capitalization: 2.2 million